Research graph
References from Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.cmet.2023.02.003
10.1016/j.cmet.2023.02.003 · External reference
10.3390/ijms23073587
10.3390/ijms23073587 · External reference
10.3389/fendo.2024.1359255
10.3389/fendo.2024.1359255 · External reference
10.1016/j.rceng.2019.10.012
10.1016/j.rceng.2019.10.012 · External reference
10.1161/circresaha.120.315913
10.1161/circresaha.120.315913 · External reference
10.1038/s41401-018-0042-6
10.1038/s41401-018-0042-6 · External reference
10.1186/s12933-024-02238-7
10.1186/s12933-024-02238-7 · External reference
10.3389/fendo.2022.851941
10.3389/fendo.2022.851941 · External reference
10.1155/2021/6620564
10.1155/2021/6620564 · External reference
10.3390/jcm12123925
10.3390/jcm12123925 · External reference
10.1016/s2213-8587(15)00044-3
10.1016/s2213-8587(15)00044-3 · External reference
10.3390/ijms25042118
10.3390/ijms25042118 · External reference
10.1056/nejmoa1812389
10.1056/nejmoa1812389 · External reference
10.1056/nejmoa1911303
10.1056/nejmoa1911303 · External reference
10.1056/nejmoa2206286
10.1056/nejmoa2206286 · External reference
10.1111/bph.15462
10.1111/bph.15462 · External reference
10.1056/nejmoa1603827
10.1056/nejmoa1603827 · External reference
10.1093/eurheartj/ehz486
10.1093/eurheartj/ehz486 · External reference
10.1007/s00018-024-05558-9
10.1007/s00018-024-05558-9 · External reference
10.1186/s12933-019-0980-4
10.1186/s12933-019-0980-4 · External reference
10.1093/cvr/cvaa256
10.1093/cvr/cvaa256 · External reference
Liraglutide plus dapagliflozin for high uric acid and microalbuminuria in diabetes mellitus complicated with metabolic syndrome
2022 · External reference
10.1186/s12933-024-02499-2
10.1186/s12933-024-02499-2 · External reference
10.1186/s12933-024-02520-8
10.1186/s12933-024-02520-8 · External reference
10.1530/joe-17-0263
10.1530/joe-17-0263 · External reference
10.3389/fendo.2018.00002
10.3389/fendo.2018.00002 · External reference
10.1016/j.amjmed.2008.03.046
10.1016/j.amjmed.2008.03.046 · External reference
10.1161/circresaha.117.311586
10.1161/circresaha.117.311586 · External reference
10.2147/dmso.s511436
10.2147/dmso.s511436 · External reference
10.1111/dom.16242
10.1111/dom.16242 · External reference
10.2337/dc22-0772
10.2337/dc22-0772 · External reference
10.3390/jcm13247497
10.3390/jcm13247497 · External reference
10.1016/j.acthis.2020.151533
10.1016/j.acthis.2020.151533 · External reference
10.1111/jcmm.16601
10.1111/jcmm.16601 · External reference
10.2174/1871530322666220827150054
10.2174/1871530322666220827150054 · External reference
10.3389/fendo.2025.1601633
10.3389/fendo.2025.1601633 · External reference
10.1016/j.molmet.2020.101102
10.1016/j.molmet.2020.101102 · External reference
10.1155/2020/5695723
10.1155/2020/5695723 · External reference
10.1080/07853890.2023.2284890
10.1080/07853890.2023.2284890 · External reference
10.3390/cells8050388
10.3390/cells8050388 · External reference
10.1074/jbc.m212831200
10.1074/jbc.m212831200 · External reference
10.3389/fcvm.2021.765071
10.3389/fcvm.2021.765071 · External reference
Coronary microvascular dysfunction in diabetes mellitus: Pathogenetic mechanisms and potential therapeutic options
2022 · External reference
10.1038/s41420-025-02491-z
10.1038/s41420-025-02491-z · External reference
10.3390/biom15050670
10.3390/biom15050670 · External reference
10.3390/life13061420
10.3390/life13061420 · External reference
10.3389/fendo.2022.862394
10.3389/fendo.2022.862394 · External reference
10.1016/j.ahj.2013.07.012
10.1016/j.ahj.2013.07.012 · External reference
10.1007/s13300-016-0197-4
10.1007/s13300-016-0197-4 · External reference
10.1161/circulationaha.119.040130
10.1161/circulationaha.119.040130 · External reference
10.1161/circulationaha.119.044183
10.1161/circulationaha.119.044183 · External reference
